Difficulty: Medium
Average Score: 78%
Practice
This drug is a Class IC antiarrhythmic drug:
Correct answer
A
Rationale
The correct answer is A) Flecainide. Flecainide is classified as a Class IC antiarrhythmic drug, which means it works by blocking sodium channels in cardiac tissues, resulting in a decrease in conduction velocity and an increase in the refractory period. This action helps to stabilize the heart's rhythm in cases of ventricular arrhythmias.
Option B) Sotalol is a Class III antiarrhythmic drug that primarily prolongs the action potential duration and repolarization in cardiac tissues.
Option C) Lidocaine is a Class IB antiarrhythmic drug that mainly works by blocking sodium channels, but its mechanism of action differs from Class IC drugs like Flecainide.
Option D) Verapamil is a calcium channel blocker and is not classified as an antiarrhythmic drug.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals, especially those working in cardiology or critical care settings. Knowing the specific mechanisms of action of each drug class helps in selecting the most appropriate medication for a patient's specific arrhythmia. This knowledge can prevent medication errors and ensure safe and effective treatment outcomes for patients.
Option B) Sotalol is a Class III antiarrhythmic drug that primarily prolongs the action potential duration and repolarization in cardiac tissues.
Option C) Lidocaine is a Class IB antiarrhythmic drug that mainly works by blocking sodium channels, but its mechanism of action differs from Class IC drugs like Flecainide.
Option D) Verapamil is a calcium channel blocker and is not classified as an antiarrhythmic drug.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals, especially those working in cardiology or critical care settings. Knowing the specific mechanisms of action of each drug class helps in selecting the most appropriate medication for a patient's specific arrhythmia. This knowledge can prevent medication errors and ensure safe and effective treatment outcomes for patients.